542
Views
48
CrossRef citations to date
0
Altmetric
Review

Bioethical issues in providing financial incentives to research participants

Pages 35-41 | Published online: 24 Jun 2015

References

  • Grady C. Payment of clinical research subjects. J Clin Invest. 2005;115(7):1681–1687.
  • Grady C, Dickert N, Jawetz T, Gensler G, Emanuel E. An analysis of US practices of paying research participants. Contemp Clin Trials. 2005;26(3):365–375.
  • Fry CL, Ritter A, Baldwin S, et al. Paying research participants: a study of current practices in Australia. J Med Ethics. 2005;31(9):542–547.
  • Ripley E, Macrina F, Markowitz M, Gennings C. Why do we pay? A national survey of investigators and IRB chairpersons. J Empir Res Hum Res Ethics. 2010;5(3):43–56.
  • Bentley JP, Thacker PG. The influence of risk and monetary payment on the research participation decision making process. J Med Ethics. 2004;30(3):293–298.
  • Tishler CL, Bartholomae S. The recruitment of normal healthy volunteers: a review of the literature on the use of financial incentives. J Clin Pharmacol. 2002;42(4):365–375.
  • Stunkel L, Grady C. More than the money: a review of the literature examining healthy volunteer motivations. Contemp Clin Trials. 2011;32(3):342–352.
  • Shamoo A, Resnik DB. Strategies to minimize risks and exploitation in phase one trials on healthy subjects. Am J Bioethics. 2006;6(3):W1–W13.
  • Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283(20):2701–2711.
  • Dickert N, Grady C. What’s the price of a research subject? Approaches to payment for research participation. N Engl J Med. 1999;341(3):198–203.
  • Wertheimer A. Is payment a benefit? Bioethics. 2013;27(2):105–116.
  • Czarny MJ, Kass NE, Flexner C, Carson KA, Myers RK, Fuchs EJ. Payment to healthy volunteers in clinical research: the research subject’s perspective. Clin Pharmacol Ther. 2010;87(3):286–293.
  • Breitkopf CR, Loza M, Vincent K, Moench T, Stanberry LR, Rosenthal SL. Perceptions of reimbursement for clinical trial participation. J Empir Res Hum Res Ethics. 2011;6(3):31–38.
  • Elliott C, Abadie R. Exploiting a research underclass in phase 1 clinical trials. N Engl J Med. 2008;358(22):2316–2317.
  • Lemmens T, Elliott C. Guinea pigs on the payroll: the ethics of paying research subjects. Account Res. 1999;7(1):3–20.
  • Department of Health and Human Services. Protection of Human Subjects. 45 CFR 46, 2009. Available from: http://www.hhs.gov/ohrp/policy/ohrpregulations.pdf. Accessed June 3, 2015.
  • Council for the International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Available from: http://www.cioms.ch/publications/guidelines/guidelines_nov_2002_blurb.htm. Accessed December 17, 2014.
  • Macklin R. On paying money to research subjects: ‘due’ and ‘undue’ inducements. IRB. 1981;3(5):1–6.
  • Faden R, Beauchamp T. A History and Theory of Informed Consent. New York, NY, USA: Oxford University Press; 1986.
  • McNeill P. Paying people to participate in research: why not? A response to Wilkinson and Moore. Bioethics. 1997;11(5):390–396.
  • Largent E, Grady C, Miller FG, Wertheimer A. Misconceptions about coercion and undue influence: reflections on the views of IRB members. Bioethics. 2013;27(9):500–507.
  • Largent EA, Grady C, Miller FG, Wertheimer A. Money, coercion, and undue inducement: attitudes about payments to research participants. IRB. 2012;34(1):1–8.
  • Klitzman R. How IRBs view and make decisions about coercion and undue influence. J Med Ethics. 2013;39(4):224–229.
  • Grady C. Money for research participation: does in jeopardize informed consent? 1. Am J Bioeth. 2001;1(2):40–44.
  • Wertheimer A, Miller FG. Payment for research participation: a coercive offer? J Med Ethics. 2008;34(5):389–392.
  • Wilkinson M, Moore A. Inducement in research. Bioethics. 1997;11(5):373–389.
  • Abadie R. The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects. Durham, NC, USA: Duke University Press; 2010.
  • Halpern SD, Karlawish JH, Casarett D, Berlin JA, Asch DA. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med. 2004;164(7):801–803.
  • Singer E, Couper MP. Do incentives exert undue influence on survey participation? Experimental evidence. J Empir Res Hum Res Ethics. 2008;3(3):49–56.
  • Mantzari E, Vogt F, Marteau TM. Does incentivising pill-taking ‘crowd out’ risk-information processing? Evidence from a web-based experiment. Soc Sci Med. 2014;106:75–82.
  • Cryder CE, London JA, Volpp KG, Loewenstein G. Informative inducement: study payment as a signal of risk. Soc Sci Med. 2010;70(3):455–464.
  • Dunn LB, Kim DS, Fellows IE, Palmer BW. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophr Bull. 2009;35(4):730–737.
  • Klitzman R. The importance of social, cultural, and economic contexts, and empirical research in examining “undue inducement”. Am J Bioeth. 2005;5(5):19–21.
  • Emanuel EJ, Currie XE, Herman A; Project Phidisa. Undue inducement in clinical research in developing countries: is it a worry? Lancet. 2005;366(9482):336–340.
  • Emanuel EJ. Ending concerns about undue inducement. J Law Med Ethics. 2004;32(1):100–105.
  • Emanuel EJ. Undue inducement: nonsense on stilts? Am J Bioeth. 2005;5(5):9–13.
  • London AJ. Undue inducements and reasonable risks: will the dismal science lead to dismal research ethics? Am J Bioeth. 2005;5(5):29–32.
  • Wertheimer A. Exploitation. Princeton, NJ, USA: Princeton University Press; 1999.
  • Wendler D, Rackoff JE, Emanuel EJ, Grady C. The ethics of paying for children’s participation in research. J Pediatr. 2002;141(2):166–171.
  • Iltis AS, DeVader S, Matsuo H. Payments to children and adolescents enrolled in research: a pilot study. Pediatrics. 2006;118(4):1546–1552.
  • Weise KL, Smith ML, Maschke KJ, Copeland HL. National practices regarding payment to research subjects for participating in pediatric research. Pediatrics. 2002;110(3):577–582.
  • [No authors listed]. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Committee on Drugs, American Academy of Pediatrics. Pediatrics. 1995;95(2):286–294.
  • Lemmens T, Miller PB. Regulating the market in human research participants. PLoS Med. 2006;3(8):e330.
  • Dickert N, Emanuel E, Grady C. Paying research subjects: an analysis of current policies. Ann Intern Med. 2002;136(5):368–373.